Editorial: Targeting mitochondrial dysfunction for the diagnosis and treatment of Alzheimer's and cognitive-related diseases

Front Pharmacol. 2024 Jul 15:15:1455646. doi: 10.3389/fphar.2024.1455646. eCollection 2024.
No abstract available

Keywords: Alzheimer’s disease; dementia; mitochondrial dysfunction; neurocognitive diseases; phosphorylation.

Publication types

  • Editorial

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.